--- title: "OKYO Pharma (OKYO.US) — 財務報表" type: "Symbol" locale: "zh-HK" url: "https://longbridge.com/zh-HK/quote/OKYO.US/norm.md" symbol: "OKYO.US" name: "OKYO Pharma" parent: "https://longbridge.com/zh-HK/quote/OKYO.US.md" datetime: "2026-03-12T07:25:56.798Z" locales: - [en](https://longbridge.com/en/quote/OKYO.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/OKYO.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/OKYO.US/norm.md) --- > 支持的語言: [English](https://longbridge.com/en/quote/OKYO.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/OKYO.US/norm.md) # OKYO Pharma (OKYO.US) — 財務報表 ## 損益表 (USD) | 指標 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -0.0346 | -0.0346 | -0.0223 | -0.0223 | -0.0399 | | ROE | 151.49% | 115.42% | 73.03% | 63.45% | 74.18% | | Revenue | - | - | - | - | - | | Net income | -1.29M | -1.29M | -1.01M | -1.01M | -1.34M | | Operating income | -1.25M | -1.25M | -1.88M | -1.88M | -1.67M | | Gross margin | - | - | - | - | - | | Net margin | - | - | - | - | - | | Profit quality | - | - | - | - | - | ## 資產負債表 (USD) | 指標 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 4.64M | 4.64M | 3.68M | 3.68M | 2.83M | | Leverage | -1.36 | -1.36 | -0.6626 | -0.6626 | -0.3915 | | BVPS | -0.0888 | -0.0888 | -0.1541 | -0.1541 | -0.2129 | | Turnover | - | - | - | - | - | | Cash & STI | 4.22M | 4.22M | 1.56M | 1.56M | 987199.00 | | Inv & Rec | - | - | - | - | - | | LT assets | 1178.00 | 1178.00 | 2035.00 | 2035.00 | 2158.00 | | Net debt | -4.03M | -4.03M | -1.56M | -1.56M | -985391.00 | ## 現金流量表 (USD) | 指標 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | -764198.00 | -764198.00 | -784798.00 | -784798.00 | -120667.00 | | Investing CF | - | - | -604.00 | -604.00 | - | | Financing CF | 2.16M | 2.16M | 1.05M | 1.05M | 275904.00 | | Free CF | -507796.00 | -169221.00 | -550462.00 | -1.65M | -740660.00 | | OCF coverage | - | - | -129933.44% | -129933.44% | - | | Repaid & issued | - | - | 474096.00 | 474096.00 | 904.00 | | CapEx | - | - | -604.00 | -604.00 | - |